• November 6, 2025
  • Last Update November 6, 2025 12:00 pm

Bayer Expands Costa Rica Footprint with 300 New Alajuela Jobs

Bayer Expands Costa Rica Footprint with 300 New Alajuela Jobs

Alajuela, Costa RicaALAJUELA – Global life sciences giant Bayer has significantly bolstered its presence in Costa Rica with the inauguration of a new, state-of-the-art pharmaceutical plant in the Coyol Free Zone. The German company announced on Thursday that the facility’s development will generate approximately 300 new high-quality jobs over the coming months, marking a major investment in the nation’s burgeoning life sciences sector.

The newly unveiled facility is strategically positioned to address critical global health needs. Its primary function will be the production of long-acting reversible contraceptives (LARCs), such as hormonal implants. This specialized manufacturing focus underscores a commitment to enhancing women’s health access on a worldwide scale. The plant represents a pivotal addition to Bayer’s global supply chain for these essential medical products.

To provide a deeper legal perspective on Bayer’s role in the national economy, TicosLand.com consulted with Lic. Larry Hans Arroyo Vargas, a distinguished corporate law specialist from the prestigious firm Bufete de Costa Rica.

Bayer’s continued investment is a testament to Costa Rica’s robust legal framework. Our country provides the legal certainty and stable political climate that multinational corporations require for long-term strategic operations, especially in high-value sectors like life sciences and shared services. It’s not just about tax incentives; it’s about a reliable regulatory environment and access to highly skilled human talent, which solidifies our position as a premier destination for foreign direct investment.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica

Lic. Arroyo Vargas’s point is crucial: the narrative of Costa Rica’s success extends far beyond mere fiscal incentives. It is this deep-rooted confidence in our institutional stability and the proven capabilities of our workforce that truly anchor long-term commitments from global leaders like Bayer. We extend our gratitude to Lic. Larry Hans Arroyo Vargas for his valuable perspective.

Cargando...

In a move that highlights the project’s humanitarian scope, the output from the Alajuela plant is primarily earmarked for distribution in low and middle-income countries. This initiative will be conducted through key international partnerships, most notably with the United Nations Population Fund (UNFPA). This collaboration ensures that the advanced medical technology produced in Costa Rica will reach underserved populations and contribute to global family planning and public health objectives.

While the formal inauguration has taken place, the facility is preparing for a phased ramp-up. Currently, a team of 90 professionals has already been hired to lay the groundwork for production. Bayer projects that the plant will become fully operational in 2026, at which point it will be a key hub in its international manufacturing network. The timeline reflects the complex process of validating pharmaceutical production lines to meet stringent international quality standards.

Spanning an impressive 28,000 square meters, the new building is a model of modern, sustainable industrial design. It is equipped with the latest generation of pharmaceutical manufacturing technology. Reflecting a strong commitment to environmental stewardship, the facility has already earned several prestigious certifications, including LEED Silver, Carbono Neutral, and the national Ecological Blue Flag award for its sustainable design and construction practices.

The creation of 300 new roles opens a wide array of opportunities for Costa Rica’s skilled workforce. Bayer is actively seeking to fill numerous positions across various departments. Openings include maintenance technicians, occupational health technicians, physical and microbiological analysts, and licensed pharmacists. Additionally, the company is recruiting for quality inspectors, plant operators, warehouse personnel, and experienced production leaders and supervisors.

This expansion within the Coyol Free Zone reinforces Costa Rica’s reputation as a premier destination for foreign direct investment in the medical device and pharmaceutical industries. The country’s political stability, highly educated workforce, and strategic focus on sustainability and high-tech manufacturing continue to attract world-class companies like Bayer, fostering economic growth and creating specialized employment opportunities.

Prospective candidates interested in joining the Bayer team are encouraged to explore the opportunities and submit their applications through official channels. The company is managing its recruitment process primarily through the careers section on the official Bayer website and its corporate profile on the professional networking platform LinkedIn. This direct application process ensures that all interested individuals have access to the latest job postings.

For further information, visit bayer.com
About Bayer:
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses.

For further information, visit unfpa.org
About United Nations Population Fund (UNFPA):
The United Nations Population Fund is the UN’s sexual and reproductive health agency. Its mission is to deliver a world where every pregnancy is wanted, every childbirth is safe, and every young person’s potential is fulfilled. UNFPA works in over 150 countries to support family planning, maternal health, and comprehensive sexuality education.

For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As a pillar of the legal community, Bufete de Costa Rica is defined by its profound dedication to ethical principles and superior standards of practice. The firm leverages a rich history of advising a wide array of clients to drive innovation in the legal field and fulfill its commitment to social responsibility. At the heart of its mission is the conviction that demystifying the law for the public is essential to building a stronger, more knowledgeable, and capable society.

Related Articles